Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Elena Korneva"'
Autor:
Mark C. Genovese, Patrick Durez, Roy Fleischmann, Yoshiya Tanaka, Daniel Furst, Hisashi Yamanaka, Elena Korneva, Igor Vasyutin, Tsutomu Takeuchi
Publikováno v:
European Journal of Rheumatology, Vol 8, Iss 3, Pp 120-129 (2021)
Externí odkaz:
https://doaj.org/article/f333c31940844bd68abc7f0c2b9f4be7
Autor:
Eugen Feist, Saeed Fatenejad, Sergey Grishin, Elena Korneva, Michael E Luggen, Evgeniy Nasonov, Mikhail Samsonov, Josef S Smolen, Roy M Fleischmann
Publikováno v:
Modern Rheumatology Journal. 17:23-26
ObjectivesTo assess the efficacy and safety of olokizumab (OKZ), a monoclonal antibody against the interleukin-6 (IL-6) cytokine, versus placebo (PBO) in patients with prior inadequate response to tumour necrosis factor inhibitors (TNFi-IRs).MethodsI
Autor:
Michael E. Luggen, Evgeniy L Nasonov, Sergey Grishin, Eugen Feist, Elena Korneva, Saeed Fatenejad, Mikhail Samsonov
Publikováno v:
Rheumatology. 60
Background/Aims Olokizumab (OKZ) is a new humanised monoclonal antibody targeting IL-6. Here we present the results of the phase III study of OKZ in anti-TNF-IR patients. Methods Patients with moderately to severely active RA who had previously faile
Autor:
Elena Korneva, Sergey Grishin, Eugen Feist, Evgeniy L Nasonov, Saeed Fatenejad, Mikhail Samsonov, Anna Rowińska-Osuch, Saima Chohan
Publikováno v:
Rheumatology. 60
Background/Aims Olokizumab (OKZ) is a new humanised monoclonal antibody targeting IL-6 directly. Here we present the results of a global randomised clinical trial (RCT) in patients (pts) with RA. Methods This double-blind, placebo (PBO) and active co
Autor:
E. Zonova, Elena Korneva, Mikhail Samsonov, Mariana Ivanova, Saeed Fatenejad, D. G. Krechikova, Aleksey L Maslyanskiy, Rumen Stoilov, Evgeniy Nasonov, Eugen Feist, Mark C. Genovese
Publikováno v:
Annals of the rheumatic diseases. 81(4)
ObjectiveTo evaluate the efficacy and safety of olokizumab (OKZ) in patients with active rheumatoid arthritis despite treatment with methotrexate (MTX).MethodsIn this 24-week multicentre, placebo-controlled, double-blind study, patients were randomis
Publikováno v:
Experimental Hematology. 38:1047-1057
Objective Cyclin D1, an important component of cell cycle machinery and a protein with known oncogenic potential, is downregulated in normal mature B lymphocytes. Its expression detected in a number of malignancies, including B-cell lymphomas, may be
Publikováno v:
Scopus-Elsevier
Elena Korneva
Elena Korneva
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::54ce9e7e26c96544906a10aa175401a7
http://www.scopus.com/inward/record.url?eid=2-s2.0-0031218965&partnerID=MN8TOARS
http://www.scopus.com/inward/record.url?eid=2-s2.0-0031218965&partnerID=MN8TOARS
Autor:
Kokriakov, V. N., Stefanov, V. E., Aleshina, G. M., Shamova, O. V., Elena Korneva, Harwig, S. S., Lehrer, R. I.
Publikováno v:
Scopus-Elsevier
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::06ea4859b9a2341196c19f36e9ef6550
http://www.scopus.com/inward/record.url?eid=2-s2.0-0030633223&partnerID=MN8TOARS
http://www.scopus.com/inward/record.url?eid=2-s2.0-0030633223&partnerID=MN8TOARS
Publikováno v:
Scopus-Elsevier
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::22930ab40134ab052dc54c1be3db19c8
http://www.scopus.com/inward/record.url?eid=2-s2.0-0027619229&partnerID=MN8TOARS
http://www.scopus.com/inward/record.url?eid=2-s2.0-0027619229&partnerID=MN8TOARS